|
|||||
|
|
Impact of Substrate‐Based Ablation of Ventricular Tachycardia on Cardiac Mortality in Patients With Implantable Cardioverter‐Defibrillators |
|
| Authors: | YUKI KOMATSU M.D. PHILIPPE MAURY M.D. FRÉDÉRIC SACHER M.D. Ph.D. PAUL KHAIRY M.D. Ph.D. MATTHEW DALY M.B.Ch.B. HAN S. LIM M.B.B.S. STEPHAN ZELLERHOFF M.D. LAURENCE JESEL M.D. ANNE ROLLIN M.D. ALEXANDRE DUPARC M.D. PIERRE MONDOLY M.D. VALERIE AURILLAC‐LAVIGNOLLE B.Sc. ASHOK SHAH M.D. ARNAUD DENIS M.D. HUBERT COCHET M.D. Ph.D. NICOLAS DERVAL M.D. MÉLÈZE HOCINI M.D. MICHEL HAÏSSAGUERRE M.D. PIERRE JAÏS M.D. |
| Affiliation: | 1. H?pital Cardiologique du Haut‐Lévêque, the Université Victor Segalen Bordeaux II, Institut LYRIC, Bordeaux, France;2. Hospital Rangueil, CHU Toulouse, Toulouse, France;3. Montreal Heart Institute, Université de Montréal, Montreal, Canada |
| Abstract: | |
| Keywords: | catheter ablation mortality substrate‐based ablation ventricular tachycardia |